Downregulation of PKD1 by shRNA results in defective osteogenic differentiation via cAMP/PKA pathway in human MG-63 cells

Journal of Cellular Biochemistry

Volumn 113, Issue 3, 2012, Pages 967-976

  Qiu, Ni ^a,b   Zhou, Honghao ^a   Xiao, Zhousheng ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Camp Pka Pathway: Mg 63; Osteogenic Differentiation; Pkd1; Shrna Knockdown

Indexed keywords

ALKALINE PHOSPHATASE; CYCLIC AMP DEPENDENT PROTEIN KINASE; FORSKOLIN; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; POLYCYSTIN 1; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2;

ADIPOGENESIS; ARTICLE; BONE DEVELOPMENT; CALCIUM CELL LEVEL; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENETIC MARKER; HUMAN; HUMAN CELL; LENTIVIRINAE; LIPID STORAGE; MOLECULAR MECHANICS; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PRIORITY JOURNAL;

ADIPOGENESIS; CALCIUM; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CILIA; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOWN-REGULATION; HUMANS; LENTIVIRUS; OSTEOBLASTS; OSTEOGENESIS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRPP CATION CHANNELS;

LENTIVIRUS;

EID: 84863269754     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23426     Document Type: Article

References (54)

1. Abdul-Majeed S, Moloney BC, Nauli SM. 2011. Mechanisms regulating cilia growth and cilia function in endothelial cells. Cell Mol Life Sci DOI: 10.1007/ s00018-011-0744-0.
2. Al-Bhalal L, Akhtar M. 2005. Molecular basis of autosomal dominant polycystic kidney disease. Adv Anat Pathol 12:126-133. (Pubitemid 40770109)
3. Bikle DD, Halloran BP. 1999. The response of bone to unloading. J Bone Miner Metab 17:233-244.
4. Boucher C, Sandford R. 2004. Autosomal dominant polycystic kidney disease (ADPKD, MIM 173900, PKD1 and PKD2 genes, protein products known as polycystin-1 and polycystin-2). Eur J Hum Genet 12:347-354. (Pubitemid 38660184)
5. Casuscelli J, Schmidt S, DeGray B, Petri ET, Celic A, Folta-Stogniew E, Ehrlich BE, Boggon TJ. 2009. Analysis of the cytoplasmic interaction between polycystin-1 and polycystin-2. Am J Physiol Renal Physiol 297:F1310-F1315.
6. Chen XZ, Vassilev PM, Basora N, Peng JB, Nomura H, Segal Y, Brown EM, Reeders ST, Hediger MA, Zhou J. 1999. Polycystin-L is a calcium-regulated cation channel permeable to calcium ions. Nature 401:383-386. (Pubitemid 29454962)
7. Epstein DJ, Marti E, Scott MP, McMahon AP. 1996. Antagonizing cAMPdependent protein kinase A in the dorsal CNS activates a conserved Sonic hedgehog signaling pathway. Development 122:2885-2894. (Pubitemid 26326519)
8. Franceschi RT, Young J. 1990. Regulation of alkaline phosphatase by 1,25-dihydroxyvitamin D3 and ascorbic acid in bone-derived cells. J Bone Miner Res 5:1157-1167. (Pubitemid 20373524)
9. Gao B, Guo J, She C, Shu A, Yang M, Tan Z, Yang X, Guo S, Feng G, He L. 2001. Mutations in IHH, encoding Indian hedgehog, cause brachydactyly type A-1. Nat Genet 28:386-388. (Pubitemid 32702431)
10. Gattone VH II, Wang X, Harris PC, Torres VE. 2003. Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist. Nat Med 9:1323-1326. (Pubitemid 37279858)
11. Harris PC, Torres VE. 2009. Polycystic kidney disease. Annu Rev Med 60: 321-337.
12. Henriksen Z, Hiken JF, Steinberg TH, Jorgensen NR. 2006. The predominant mechanism of intercellular calcium wave propagation changes during longterm culture of human osteoblast-like cells. Cell Calcium 39:435-444.
13. Jackson PK. 2011. Do cilia put brakes on the cell cycle? Nat Cell Biol 13:340-342.
14. Janderova L, McNeil M, Murrell AN, Mynatt RL, Smith SR. 2003. Human mesenchymal stem cells as an in vitro model for human adipogenesis. Obes Res 11:65-74. (Pubitemid 41137540)
15. Jones GN, Pringle DR, Yin Z, Carlton MM, Powell KA, Weinstein MB, Toribio RE, La Perle KM, Kirschner LS. 2010. Neural crest-specific loss of Prkar1acauses perinatal lethality resulting from defects in intramembranous ossification. Mol Endocrinol 24:1559-1568.
16. Kamioka H, Sugawara Y, Murshid SA, Ishihara Y, Honjo T, Takano-Yamamoto T. 2006. Fluid shear stress induces less calcium response in asingle primary osteocyte than in a single osteoblast: Implication of different focal adhesion formation. J Bone Miner Res 21:1012-1021. (Pubitemid 43962830)
17. Kip SN, Hunter LW, Ren Q, Harris PC, Somlo S, Torres VE, Sieck GC, Qian Q. 2005. [Ca2+]i reduction increases cellular proliferation and apoptosis in vascular smooth muscle cells: Relevance to the ADPKD phenotype. Circ Res 96:873-880. (Pubitemid 40604971)
18. Koh AJ, Beecher CA, Rosol TJ, McCauley LK. 1999. 30,50-Cyclic adenosine monophosphate activation in osteoblastic cells: Effects on parathyroid hormone-1 receptors and osteoblastic differentiation in vitro. Endocrinology 140:3154-3162. (Pubitemid 30650631)
19. Kwon RY, Temiyasathit S, Tummala P, Quah CC, Jacobs CR. 2010. Primary cilium-dependent mechanosensing is mediated by adenylyl cyclase 6 and cyclic AMP in bone cells. FASEB J 24:2859-2868.
20. Maeda Y, Nakamura E, Nguyen MT, Suva LJ, Swain FL, Razzaque MS, Mackem S, Lanske B. 2007. Indian Hedgehog produced by postnatal chondrocytes is essential for maintaining a growth plate and trabecular bone. Proc Natl Acad Sci USA 104:6382-6387. (Pubitemid 47186103)
21. Marfella-Scivittaro C, Quinones A, Orellana SA. 2002. cAMP-dependent protein kinase and proliferation differ in normal and polycystic kidney epithelia. Am J Physiol Cell Physiol 282:C693-C707. (Pubitemid 34663132)
22. Meldolesi J. 2008. Inhibition of adipogenesis: A new job for the ER Ca2+ pool. J Cell Biol 182:11-13. (Pubitemid 352008615)
23. Nagata A, Tanaka T, Minezawa A, Poyurovsky M, Mayama T, Suzuki S, Hashimoto N, Yoshida T, Suyama K, Miyata A, Hosokawa H, Nakayama T, Tatsuno I. 2009. cAMP activation by PACAP/VIP stimulates IL-6 release and inhibits osteoblastic differentiation through VPAC2 receptor in osteoblastic MC3T3 cells. J Cell Physiol 221:75-83.
24. Nauli SM, Alenghat FJ, Luo Y, Williams E, Vassilev P, Li X, Elia AE, Lu W, Brown EM, Quinn SJ, Ingber DE, Zhou J. 2003. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat Genet 33:129-137. (Pubitemid 36177063)
25. Nauli SM, Rossetti S, Kolb RJ, Alenghat FJ, Consugar MB, Harris PC, Ingber DE, Loghman-Adham M, Zhou J. 2006. Loss of polycystin-1 in human cystlining epithelia leads to ciliary dysfunction. J Am Soc Nephrol 17:1015-1025.
26. Neal JW, Clipstone NA. 2002. Calcineurin mediates the calcium-dependent inhibition of adipocyte differentiation in 3T3-L1cells. J Biol Chem 277:49776-49781. (Pubitemid 36014424)
27. Praetorius HA, Spring KR. 2001. Bending the MDCK cell primary cilium increases intracellular calcium. J Membr Biol 184:71-79. (Pubitemid 33016173)
28. Praetorius HA, Spring KR. 2003. Removal of the MDCK cell primary cilium abolishes flow sensing. J Membr Biol 191:69-76. (Pubitemid 37011467)
29. Qian Q, Hunter LW, Li M, Marin-Padilla M, Prakash YS, Somlo S, Harris PC, Torres VE, Sieck GC. 2003. Pkd2 haploinsufficiency alters intracellular calcium regulation in vascular smooth muscle cells. Hum Mol Genet 12: 1875-1880. (Pubitemid 36944141)
30. Qiu N, Cao L, David V, Quarles LD, Xiao Z. 2010. Kif3a deficiency reverses the skeletal abnormalities in Pkd1 deficient mice by restoring the balance between osteogenesis and adipogenesis. PLoS One 5:e15240.
31. Saraga-Babic M, Vukojevic K, Bocina I, Drnasin K, Saraga M. 2011. Ciliogenesis in normal human kidney development and post-natal life. Pediatr Nephrol DOI: 10.1007/s00467-011-1941-7.
32. Shiba D, Takamatsu T, Yokoyama T. 2005. Primary cilia of inv/inv mouse renal epithelial cells sense physiological fluid flow: Bending of primary cilia and Ca2+ influx. Cell Struct Funct 30:93-100.
33. Starremans PG, Li X, Finnerty PE, Guo L, Takakura A, Neilson EG, Zhou J. 2008. A mouse model for polycystic kidney disease through a somatic in-frame deletion in the 50 end of Pkd1. Kidney Int 73:1394-1405. (Pubitemid 351770482)
34. Sun C, Wang L, Yan J, Liu S. 2011. Calcium ameliorates obesity induced by high-fat diet and its potential correlation with p38 MAPK pathway. Mol Biol Rep DOI: 10.1007/s11033-011-0916-x.
35. Sutters M, Yamaguchi T, Maser RL, Magenheimer BS, St John PL, Abrahamson DR, Grantham JJ, Calvet JP. 2001. Polycystin-1 transforms the cAMP growth-responsive phenotype of M-1cells. Kidney Int 60:484-494. (Pubitemid 32678892)
36. Szabo E, Qiu Y, Baksh S, Michalak M, Opas M. 2008. Calreticulin inhibits commitment to adipocyte differentiation. J Cell Biol 182:103-116. (Pubitemid 352008625)
37. Tintut Y, Parhami F, Le V, Karsenty G, Demer LL. 1999. Inhibition of osteoblast-specific transcription factor Cbfa1 by the cAMP pathway in osteoblastic cells. Ubiquitin/proteasome-dependent regulation. J Biol Chem 274:28875-28879.
38. Tsang KM, Starost MF, Nesterova M, Boikos SA, Watkins T, Almeida MQ, Harran M, Li A, Collins MT, Cheadle C, Mertz EL, Leikin S, Kirschner LS, Robey P, Stratakis CA. 2010. Alternate protein kinase A activity identifies aunique population of stromal cells in adult bone. Proc Natl Acad Sci USA 107:8683-8688.
39. Tsuang YH, Sun JS, Chen LT, Sun SC, Chen SC. 2006. Direct effects of caffeine on osteoblastic cells metabolism: The possible causal effect of caffeine on the formation of osteoporosis. J Orthop Surg Res 1:7.
40. Wallace DP. 2011. Cyclic AMP-mediated cyst expansion. Biochim Biophys Acta 1812:1291-1300.
41. Wang W, Zhang X, Zheng J, Yang J. 2010. High glucose stimulates adipogenic and inhibits osteogenic differentiation in MG-63cells through cAMP/ protein kinase A/extracellular signal-regulated kinase pathway. Mol Cell Biochem 338:115-122.
42. Wilson PD. 2004. Polycystic kidney disease. N Engl J Med 350:151-164. (Pubitemid 38056226)
43. Xia SL, Ferrier J. 1992. Propagation of a calcium pulse between osteoblastic cells. Biochem Biophys Res Commun 186:1212-1219. (Pubitemid 23189453)
44. Xiao ZS, Quarles LD. 2010. Role of the polycytin-primary cilia complex in bone development and mechanosensing. Ann N Y Acad Sci 1192:410-421.
45. Xiao ZS, Hjelmeland AB, Quarles LD. 2004. Selective deficiency of the ''bone-related'' Runx2-II unexpectedly preserves osteoblast-mediated skeletogenesis. J Biol Chem 279:20307-20313. (Pubitemid 38623476)
46. Xiao Z, Zhang S, Mahlios J, Zhou G, Magenheimer BS, Guo D, Dallas SL, Maser R, Calvet JP, Bonewald L, Quarles LD. 2006. Cilia-like structures and polycystin-1 in osteoblasts/osteocytes and associated abnormalities in skeletogenesis and Runx2 expression. J Biol Chem 281:30884-30895. (Pubitemid 44582143)
47. Xiao Z, Zhang S, Magenheimer BS, Luo J, Quarles LD. 2008. Polycystin-1 regulates skeletogenesis through stimulation of the osteoblast-specific transcription factor RUNX2-II. J Biol Chem 283:12624-12634.
48. Xiao Z, Zhang S, Cao L, Qiu N, David V, Quarles LD. 2010. Conditional disruption of Pkd1 in osteoblasts results in osteopenia due to direct impairment of bone formation. J Biol Chem 285:1177-1187.
49. Xiao Z, Dallas M, Qiu N, Nicolella D, Cao L, Johnson M, Bonewald L, Quarles LD. 2011. Conditional deletion of Pkd1 in osteocytes disrupts skeletal mechanosensing in mice. FASEB J 25:2418-2432.
50. Yamaguchi T, Pelling JC, Ramaswamy NT, Eppler JW, Wallace DP, Nagao S, Rome LA, Sullivan LP, Grantham JJ. 2000. cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway. Kidney Int 57:1460-1471. (Pubitemid 30207906)
51. Yamaguchi T, Wallace DP, Magenheimer BS, Hempson SJ, Grantham JJ, Calvet JP. 2004. Calcium restriction allows cAMP activation of the B-Raf/ ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype. J Biol Chem 279:40419-40430. (Pubitemid 39287631)
52. Yamaguchi T, Hempson SJ, Reif GA, Hedge AM, Wallace DP. 2006. Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells. J Am Soc Nephrol 17:178-187.
53. Yang DC, Tsay HJ, Lin SY, Chiou SH, Li MJ, Chang TJ, Hung SC. 2008. cAMP/ PKA regulates osteogenesis, adipogenesis and ratio of RANKL/OPG mRNA expression in mesenchymal stem cells by suppressing leptin. PLoS One 3:e1540.
54. Yoder BK, Mulroy S, Eustace H, Boucher C, Sandford R. 2006. Molecular pathogenesis of autosomal dominant polycystic kidney disease. Expert Rev Mol Med 8:1-22. (Pubitemid 43125675)